
    
      The aim of this study is to identify the biomarkers in patients with pneumonia. These
      biomarkers can distinguish community-acquired pneumonia, hospital-acquired pneumonia, severe
      pneumonia, bacterial infection, virus infection and fungal infection. Furthermore, these
      biomarkers can identify the efficacy of treatment in patients with different interventions.
    
  